Skip to main content
. 2013 Nov 7;306(1):G72–G80. doi: 10.1152/ajpgi.00178.2013

Fig. 3.

Fig. 3.

Effects of RTK inhibition on portal hypertension and hepatic fibrosis in experimental hepatopulmonary syndrome (HPS). Graphical summaries of portal venous pressure (PVP), spleen weight, and hepatic α-smooth muscle actin (α-SMA) mRNA levels after CBDL. Values are expressed as means ± SE (n = 8 animals for each group). *P < 0.05 compared with sham. ‡P < 0.05 compared with CBDL.